Table 4.
ΔBMI | ΔMAP | ΔHOMA | ΔTotal MVO2 | ΔLV mass | ΔTotal myocardial fatty acid utilization | |
---|---|---|---|---|---|---|
| ||||||
ΔE’ | r=-0.46 | r=-0.01 | r=-0.41 | r=0.56 | r=0.56 | r=0.18 |
P=0.01 | P=0.95 | P=0.03 | P=0.002 | P=0.002 | P=0.37 |
B. Independent predictors of LV relaxation improvement. | |||||||
Multivariate analyses | |||||||
All subjects | Women only | ||||||
R2 | ΔBMI | ΔTotal MVO2 | R2 | ΔBMI | ΔTotal MVO2 | ||
ΔE’ | 0.34 | P=0.33 | P<0.03 | ΔE’ | 0.55 | P=0.38 | P=0.003* |
ΔBMI | LV mass change | ΔBMI | ΔLV mass | ||||
ΔE’ | 0.35 | P=0.32 | P<0.03 | ΔE’ | 0.33 | P=0.20 | P=0.14 |
ΔBMI | HOMA change | ΔBMI | ΔHOMA | ||||
ΔE’ | 0.26 | P=0.08 | P=0.19 | ΔE’ | 0.32 | P=0.11 | P=0.19 |
HOMA = homeostasis model index, LV = left ventricular, MVO2 = myocardial oxygen consumption